SAN MATEO, Calif. and CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a...
SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a...
Phase 1b portion of phase 1b/2 lanraplenib study in patients withย relapsed/refractory FLT3-mutated acute...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.